"Trattamento a lungo termine della psoriasi artropatica con etanercept: studio di tre anni."

Poster 1° classificato al Lyfe Cycle Derma day. del 24 e 25 Settembre 2009 Roma

Principali Pubblicazioni Scientifiche

Riportiamo l'elenco dei principali articoli di carattere scientifico pubblicati dalla dottoressa Mazzotta:

- Safety and Efficacy Studies on Etanercept in Patients With Plaque Psoriasis.
A.Costanzo, A.Mazzotta, M.Papoutsaki, S.Nisticò, S.Chimenti . Br J Dermatol. 2005 Jan;152(1):187-9.

- Etanercept for the treatment of severe childhood psoriasis
M. Papoutsaki ,A. Costanzo, A. Mazzotta, T. Gramiccia , R.Soda, S. Chimenti. Br J Dermatol. 2006 Jan;154(1):181-3. European Academy of Dermatology and Venereology (EADV)

- Treatment of erytrodermic psoriasis with etanercept
M.Esposito, A.Mazzotta, C.de Felice, M. Papoutsaki, and S.Chimenti British Journal of Dermatology Jul 2006 155(1):156-9.

- Severe acne successfully treated with etanercept
E. Campione, A. Mazzotta, L.Bianchi, S.Chimenti. Acta Derm Venereol. 2006;86(3):256-7

- Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene
Campione E, Terrinoni A, Orlandi A, Codispoti A, Melino G, Bianchi L, Mazzotta A, Garaci FG, Ludovici A, Chimenti S. J Invest Dermatol. 2007 Sep;127(9):2271-3. Epub 2007 May 3.

- Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis
A. Mazzotta, M. Esposito, I. Carboni, C. Schipani, S. Chimenti. J Dermatolog Treat.2007; 18(2):84-7.

- Consecutive use of different biological therapies in the treatment of psoriasis
Costanzo A, Papoutsaki M, Mazzotta A, Chimenti S. Br J Dermatol. 2007 Aug;157(2):394. Epub 2007 Jun 6.

- High-Dose Initiation Of etanercept in psoriatic arthritis and plaque psoriasis: efficacy , safety and inpact on patients quality of life.
C. De Felice, A.Mazzotta, M.Esposito, L.Bianchi, S.Chimenti. J Dermatolog Treat. 2006;17(6):355-8

- Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series.
Esposito M, Mazzotta A, Casciello C, Chimenti S.Dermatology. 2008;216(4):355-60. Epub 2008 Feb 20

- Long-term efficacy of etanercept in hidradenitis suppurativa.
Zangrilli A, Esposito M, Mio G, Mazzotta A, Chimenti S.J Eur Acad Dermatol Venereol. 2008 Nov;22(10):1260-2. Epub 2008 Mar 7

- Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis.
Saraceno R, Schipani C, Mazzotta A, Esposito M, Di Renzo L, De Lorenzo A, Chimenti S. Pharmacol Res. 2008 Apr;57(4):290-5. Epub 2008 Feb 29.

- Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis.
Esposito M, Mazzotta A, Saraceno R, Schipani C, Chimenti S. Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):219-25

- Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
Campione E, Mazzotta A, Paternò EJ, Diluvio L, Prinz JC, Chimenti S. Acta Derm Venereol. 2009;89(3):288-91

- Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A, Esposito M, Costanzo A, Chimenti S. Am J Clin Dermatol. 2009;10(5):319-24. doi: 10.2165/11310770-000000000-00000.

- Involvement of IL-21 in the epidermal hyperplasia of psoriasis.
Roberta Caruso, Elisabetta.Botti, Massimiliano Sarra, Maria Esposito, Carmine Stolfi, Laura Diluvio, Maria Laura Giustizieri, Valentina Pacciani, Annamaria Mazzotta, Elena Campione, Thomas T MacDonald, Sergio Chimenti, Francesco Pallone, Antonio Costanzo, Giovanni Monteleone1. Nat Med. 2009 Sep;15(9):1013-5. Epub 2009 Aug 16.

- Long-term experience with etanercept in psoriatic arthritis patients: a 3-year observational study.
Mazzotta A, Esposito M, Schipani C, Chimenti S. J Dermatolog Treat. 2009;20(6):354-8

- A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy.
Colombo GL, Di Matteo S, Peris K, Fargnoli MC, Esposito M, Mazzotta A, Chimenti S. Clinicoecon Outcomes Res. 2009;1:53-9. Epub 2009 Oct 15.

- Continuous treatment of plaque-type psoriasis with etanercept: an observational long-term experience.
Esposito M, Giunta A, Mazzotta A, Babino G, Talamonti M, Chimenti MS, Chimenti S. Int J Immunopathol Pharmacol. 2010 Apr-Jun; 23(2):503-9.

- IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-?-dependent epidermal hyperplasia.
Sarra M, Caruso R, Cupi ML, Monteleone I, Stolfi C, Campione E, Diluvio L, Mazzotta A, Botti E, Chimenti S, Costanzo A, MacDonald TT, Pallone F, Monteleone G. J Immunol. 2011 May 1;186(9):5435-42. Epub 2011 Mar 25.

- Etanercept, childhood and long-term safety: a case of five years treatment.
Mazzotta A, Saraceno R, Esposito M, Chimenti S. Eur J Dermatol. 2011 Sep-Oct;21(5):776-7.

- Detection and management of latent tuberculosis infections before biologic therapy for psoriasis.
Amerio P, Amoruso G, Bardazzi F, Campanati A, Cassano N, Conti A, Gisondi P, Guarneri C, Mazzotta A, Piaserico S, Prestinari F, Prignano F, Zane C, de Simone C. J Dermatolog Treat. 2012 Jan 31.

Si riportano di seguito i principali Abstract pubblicati su riviste indexate:


1. High-dose initiation of etanercept in plaque psoriasis and psoriatic arthritis: an italian experience.
A. Mazzotta, C. de Felice, M. Esposito, M. Ruzzetti and S. Chimenti. Br J Dermatol 2006, 154: 1-10

2. Safety and efficacy of etanercept in patients with plaque psoriasis
Costanzo A, Mazzotta A, Papoutsaki M, Saraceno R, Nisticò S, Chimenti S. Department of Dermatology, University of Rome “Tor Vergata”, Italy J Eur Acad Dermatol 2004 Nov, Volume 18, Suppl 2: 345

3. Etanercept and quality of life in patients with psoriasis
M. Talamonti, M. Papoutsaki, A. Mazzotta, A. Zangrilli and S. Chimenti 4th International Congress The Royal College of Physicians, Br J Dermatol 2006, 154: 1-10

4. Previous biological therapies influence the rate of response to etanercept in chronic plaque psoriasis
A. Costanzo, M. Papoutsaki, A. Mazzotta, T. Gramiccia and S. Chimenti 4th International Congress Br J Dermatol 2006, 154: 1-10

5. Efficacy And Safety of high-dose initiation of Etanercept In Psoriatic Arthritis
C. de Felice, L. Bianchi, A. Mazzotta, S. Chimenti (P2815)AAD2006

6. Efficacy and safety of etanercept in moderate-to-severe plaque psoriasis using two different dosing regimens.
A. Mazzotta, A. Costanzo, A. Giunta, S. Chimenti(P2814)AAD2006

7. Muir-Torre Syndrome with Fatal Outcome
E.Campione, A.Orlandi, A.Mazzotta, L.Bianchi, M.Esposito, G.Mio and S. Chimenti. Journal of Investigative Dermatology,vol.126 supplement July 2006

8. Consecutive use of different biological therapies in the treatmet of psoriasis.
A, Papoutsaki M, Mazzotta A, Chimenti S.Br J Dermatol 2007 Jun 6; [ Epub ahead of print].

La Dottoressa è inoltre autrice di alcuni capitoli di libri scientifici dermatologici:

-Methotrexate: Psoriasis Chapter 16 Systemic treatments Ricozzi I, Saraceno R, Mazzotta A, Chimenti S.- SEE-Firenze 2005.

-Etanercept: Psoriasis Chapter 21 Biologicals Mazzotta A, Soda R, Chimenti S.- SEE-Firenze 2005

 


     
  Dott.ssa Annamaria Mazzotta, Via Foscolo N°2, Roma 00185
Tel. 06 77203592- P.IVA 01004890568

a.mazzotta@inwind.it

realizzato da DEGIMWEB